BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 14974906)

  • 1. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly.
    Lombardi G; Colao A; Marzullo P; Ferone D; Longobardi S; Esposito V; Merola B
    J Endocrinol; 1997 Oct; 155 Suppl 1():S33-7; discussion S39. PubMed ID: 9389993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study.
    Bogazzi F; Di Bello V; Palagi C; Donne MG; Di Cori A; Gavioli S; Talini E; Cosci C; Sardella C; Brogioni S; Mariani M; Martino E
    Clin Endocrinol (Oxf); 2005 May; 62(5):590-6. PubMed ID: 15853830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac IGF-I manipulation by growth hormone following myocardial infarction.
    Matthews KG; Devlin GP; Stuart SP; Conaglen JV; Bass JJ
    Growth Horm IGF Res; 2004 Jun; 14(3):251-60. PubMed ID: 15125887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone and the heart.
    Saccà L; Cittadini A; Fazio S
    Endocr Rev; 1994 Oct; 15(5):555-73. PubMed ID: 7843068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does growth hormone play a role in chronic heart failure?
    Volterrani M; Giustina A; Lorusso R; Giordano A
    Heart Fail Monit; 2002; 3(2):60-4. PubMed ID: 12634881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide and the mediation of the hemodynamic effects of growth hormone in humans.
    Böger RH
    J Endocrinol Invest; 1999; 22(5 Suppl):75-81. PubMed ID: 10442575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in growth hormone/insulin-like growth factor-1 axis in patients with normal pituitary function and biventricular cardiac failure and hepatic stasis].
    Mangieri E; Tosti-Croce C; Tanzilli G; Barillà F; Nardi M; Poggi M; Ciavolella M; Farinelli A; Mangiaracina F; Campa PP
    Cardiologia; 1996 May; 41(5):449-53. PubMed ID: 8767634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and metabolic effects of recombinant human growth hormone in cardiac insufficiency].
    Modlińska A; Babińska A; Faran G; Sworczak K
    Przegl Lek; 2003; 60(5):349-52. PubMed ID: 14593678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the GH/IGF-I axis for cardiac function and structure.
    Isgaard J; Tivesten A; Friberg P; Bengtsson BA
    Horm Metab Res; 1999; 31(2-3):50-4. PubMed ID: 10226781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone increases the proliferation of existing cardiac myocytes and the total number of cardiac myocytes in the rat heart.
    Brüel A; Christoffersen TE; Nyengaard JR
    Cardiovasc Res; 2007 Dec; 76(3):400-8. PubMed ID: 17673190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.
    Jayasankar V; Pirolli TJ; Bish LT; Berry MF; Burdick J; Grand T; Woo YJ
    J Mol Cell Cardiol; 2004 Apr; 36(4):531-8. PubMed ID: 15081312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
    Moreira VO; Pereira CA; Silva MO; Felisbino SL; Cicogna AC; Okoshi K; Aragon FF; Padovani CR; Okoshi MP; Castro AV
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):325-30. PubMed ID: 19278522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular complications in acromegaly.
    Vitale G; Pivonello R; Lombardi G; Colao A
    Minerva Endocrinol; 2004 Sep; 29(3):77-88. PubMed ID: 15282442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart in pituitary diseases.
    Hradec J; Marek J; Král J; Simper D; Spácil J
    Cor Vasa; 1992; 34(2):101-7. PubMed ID: 1304450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.